Clinical Research Directory
Browse clinical research sites, groups, and studies.
LED Red Light in Modulating Choroidal Microcirculation to Retard Retinal Atrophy in Pathological Myopia
Sponsor: Shanghai Eye Disease Prevention and Treatment Center
Summary
The goal of this clinical trial is to learn if repeated low-level red light (RLRL) therapy works to treat pathologic myopia in adults. It will also learn about the safety of RLRL. The main questions it aims to answer are: Does RLRL modulate choroidal microcirculation to retard retinal atrophy in pathological myopia? What medical problems do participants have when receiving RLRL therapy? Researchers will compare RLRL to a sham RLRL device (identical in appearance but delivering \<10% of the original device's energy output) to see if RLRL works to treat pathologic myopia. Participants will: Take RLRL or sham RLRL twice daily, 3 minutes per session, 5 days per week, for a total duration of 12 months. Visit the clinic once every 3 months for checkups and tests Keep a diary of their symptoms and their visual perception
Official title: A Randomized Controlled Trial of LED Red Light in Modulating Choroidal Microcirculation to Retard Retinal Atrophy in Pathological Myopia
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
158
Start Date
2025-12-31
Completion Date
2028-12-30
Last Updated
2025-12-31
Healthy Volunteers
No
Conditions
Interventions
LED red light
An RLRL device (660 nm, 65 mW/cm²). Twice daily, 3 minutes per session, 5 days per week, for a total duration of 12 months.
Sham LED red light
A sham RLRL device (identical in appearance but delivering \<10% of the original device's energy output) . Twice daily, 3 minutes per session, 5 days per week, for a total duration of 12 months.
Locations (1)
Shanghai Eye Disease Prevention and Treatment Center
Shanghai, China